These are some of the top analyst upgrades, downgrades and initiations seen from Wall S. research calls this Monday morning.
Biogen Idec Inc. (NASDAQ: BIIB) started as Outperform at Leerink Swann.
Cinemark Holdings (NYSE: CNK) started as Neutral at Goldman Sachs.
Deckers Outdoor Corp. (NASDAQ: DECK) cut to Underperform at Stern Agee.
Exa Corp. (NASDAQ: EXA) started as Buy at Canaccord Genuity and started as Buy at Needham.
Human Genome Sciences Inc. (NASDAQ: HGSI) cut to Hold at Maxim Group.
IMAX Corp. (NYSE: IMAX) started as Buy at Goldman Sachs.
KB Home (NYSE: KBH) raised to Buy at Goldman Sachs.
Marriott International (NYSE: MAR) maintained as Buy but removed from Conviction Buy List at Goldman Sachs.
MDC Holdings (NYSE: MDC) raised to Conviction Buy List at Goldman Sachs.
Mosaic Co. (NYSE: MOS) raised to Buy at Citigroup.
NVR Inc. (NYSE: NVR) cut to Sell at Goldman Sachs.
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) raised to Buy at Jefferies.
Regal Entertainment Corp. (NYSE: RGC) started as Neutral at Goldman Sachs.
Ryland Group (NYSE: RYL) raised to Neutral at Goldman Sachs.
Schlumberger Ltd. (NYSE: SLB) raised to Buy at Argus.
Sempra Energy (NYSE: SRE) cut to Hold at Argus.
VeriSign Inc. (NASDAQ: VRSN) cut to Neutral at Citigroup.
Walgreen Co. (NYSE: WAG) cut to Neutral at UBS.
JON C. OGG